Sanofi

Sanofi Sells 11 CNS Assets to Pharmanovia including Frisium and Gardenal
Sanofi Sells 11 CNS Assets to Pharmanovia including Frisium and Gardenal
BioSpace
Sanofi
Pharmanovia
CNS
Frisium
Gardenal
Flag link:
Sanofi Consumer Healthcare’s Road To Sustainability And B Corp Certification
Sanofi Consumer Healthcare’s Road To Sustainability And B Corp Certification
Forbes
Sanofi
consumer health
sustainability
Flag link:
Madrigal's stock shaken with CEO change up, as Sanofi's Sibold takes the reins
Madrigal's stock shaken with CEO change up, as Sanofi's Sibold takes the reins
Fierce Biotech
Madrigal Pharmaceuticals
Pharma CEOs
Sanofi
Bill Sibold
NASH
Flag link:
Sanofi appoints a venture investor to R&D head as executive team expands
Sanofi appoints a venture investor to R&D head as executive team expands
BioPharma Dive
Sanofi
R&D
Houman Ashrafian
Flag link:
US senators push drugmakers for details on low-cost insulin programs
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Senate
insulin
drug pricing
Novo Nordisk
Eli Lilly
Sanofi
diabetes
Flag link:
5 of the best places to work in pharma, according to employees
5 of the best places to work in pharma, according to employees
Pharma Voice
Glassdoor
Merck
JNJ
Pfizer
GSK
Sanofi
Flag link:
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Clinical Trials Arena
Pfizer
AstraZeneca
Sanofi
Abrysvo
Beyfortus
RSV
Flag link:
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Eli Lilly
Retevmo
thyroid cancer
medullary thyroid cancer
clinical trials
Exelixis
Capometyx
Sanofi
Caprelsa
Flag link:
10 clinical trials to watch in the second half of 2023
10 clinical trials to watch in the second half of 2023
BioPharma Dive
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Flag link:
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children
Stat
CDC
RSV
infants
monoclonal antibodies
Sanofi
Beyfortus
Flag link:
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data
Fierce Biotech
Sanofi
BioNTech
MRNA
cytokines
cancer
Flag link:
Sanofi goes oral route in Recludix deal to develop tailored I&I drugs
Sanofi goes oral route in Recludix deal to develop tailored I&I drugs
Medical Marketing and Media
Sanofi
Recludix Pharma
inflammatory diseases
drug development
Flag link:
Scratching the surface of the urticaria pipeline
Scratching the surface of the urticaria pipeline
EP Vantage
chronic urticaria
Sanofi
Dupixent
Regeneron
Novartis
Roche
Xolair
Allakos
AstraZeneca
Celldex Therapeutics
Flag link:
CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus
CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus
Fierce Pharma
CDC
Sanofi
AstraZeneca
RSV
Beyfortus
Flag link:
Sanofi expands research deal with gene editing startup Scribe
Sanofi expands research deal with gene editing startup Scribe
BioPharma Dive
Sanofi
gene editing
Scribe Therapeutics
Flag link:
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
BioSpace
Sanofi
AstraZeneca
Beyfortus
nirsevimab
RSV
infants
pediatric
FDA
Flag link:
Dupixent goes back-to-back as top Rx, OTC pharma brand in June
Dupixent goes back-to-back as top Rx, OTC pharma brand in June
Medical Marketing and Media
Dupixent
Sanofi
Regeneron
Flag link:
Sanofi blocks Sandoz's Jevtana generic in patent win
Sanofi blocks Sandoz's Jevtana generic in patent win
Fierce Pharma
Sanofi
Jevtana
generics
Sandoz
prostate cancer
legal
Flag link:
Sanofi outlines five-pronged approach to reel in €10B in vaccine sales by 2030
Sanofi outlines five-pronged approach to reel in €10B in vaccine sales by 2030
Fierce Pharma
Sanofi
vaccines
R&D
Flag link:
Sanofi says it's back to the drawing board on mRNA flu vaccines
Sanofi says it's back to the drawing board on mRNA flu vaccines
Reuters
Sanofi
vaccines
MRNA
flu vaccines
Flu
Flag link:

Pages